Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy.

PubWeight™: 1.79‹?› | Rank: Top 3%

🔗 View Article (PMC 3144145)

Published in Gastrointest Endosc on April 01, 2010

Authors

Bruce D Greenwald1, John A Dumot, Julian A Abrams, Charles J Lightdale, Donald S David, Norman S Nishioka, Patrick Yachimski, Mark H Johnston, Nicholas J Shaheen, Alvin M Zfass, Jenny O Smith, Kanwar Rupinder S Gill, J Steven Burdick, Damien Mallat, Herbert C Wolfsen

Author Affiliations

1: Division of Gastroenterology and Hepatology, University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore, Maryland 21201-1595, USA.

Associated clinical trials:

TruFreeze™ Airway Obstruction: TAO STUDY (TAO) | NCT01903850

Spray Cryotherapy for Esophageal Cancer (ICE-CANCER) (ICE-CANCER) | NCT01868139

trūFreeze® Spray Cryotherapy Patient Registry | NCT01802203

Articles citing this

Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21

Spray cryotherapy is effective for bronchoscopic, endoscopic and open ablation of thoracic tissues. Interact Cardiovasc Thorac Surg (2012) 1.00

Barrett's esophagus: endoscopic treatments II. Ann N Y Acad Sci (2011) 0.92

Predictors of esophageal stricture formation post endoscopic mucosal resection. Clin Endosc (2014) 0.84

Barrett's esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) (2013) 0.83

Palliative Endoscopic Therapy of Esophageal Cancer. Viszeralmedizin (2015) 0.80

Endoscopic management of Barrett's esophagus: advances in endoscopic techniques. Dig Dis Sci (2012) 0.78

Endoscopic assessment and management of early esophageal adenocarcinoma. World J Gastrointest Oncol (2014) 0.76

Cryotherapy for the eradication of barrett esophagus or early cancer. Gastroenterol Hepatol (N Y) (2012) 0.75

Feasibility and safety of endoscopic cryoablation at the duodenal papilla: Porcine model. World J Gastrointest Endosc (2015) 0.75

Upper gastrointestinal tumors. Endoscopy (2011) 0.75

Cryotherapy for the prevention and treatment of esophageal cancer: when does efficacy equal success? Gastrointest Endosc (2010) 0.75

Current status of spray cryotherapy for airway disease. J Thorac Dis (2017) 0.75

Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA. Biomed Res Int (2014) 0.75

Endoscopic applications of cryospray ablation therapy-from Barrett's esophagus and beyond. World J Gastrointest Endosc (2016) 0.75

Endoscopic management of Barrett esophagus. Nat Rev Gastroenterol Hepatol (2011) 0.75

Endoscopic Cryotherapy for Barrett Esophagus. Gastroenterol Hepatol (N Y) (2015) 0.75

Metered Cryospray™: a novel uniform, controlled, and consistent in vivo application of liquid nitrogen cryogenic spray. Med Devices (Auckl) (2017) 0.75

Large Bowel Obstruction following Endoscopic Spray Cryotherapy for Palliation of Rectal Cancer Bleeding. ACG Case Rep J (2017) 0.75

Endoscopic spray cryotherapy for genitourinary malignancies: safety and efficacy in a porcine model. Ther Adv Urol (2013) 0.75

Endoscopic resection of gastric and esophageal cancer. Gastroenterol Rep (Oxf) (2015) 0.75

Efficacy and safety of liquid nitrogen cryotherapy for treatment of Barrett's esophagus. World J Gastrointest Endosc (2017) 0.75

Articles cited by this

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol (2008) 7.01

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol (2007) 6.08

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol (2005) 5.19

Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc (2007) 4.28

A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol (2008) 3.54

Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc (2003) 2.80

Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg (2005) 2.28

Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc (2005) 2.25

Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology (2009) 1.88

Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol (2003) 1.82

Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg (2007) 1.81

Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg (2008) 1.73

Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc (2005) 1.71

Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc (2008) 1.69

Chemoradiation in the management of esophageal cancer. J Clin Oncol (2007) 1.68

Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis. Gastrointest Endosc (2009) 1.57

Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy (2008) 1.54

An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc (2009) 1.44

Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus (2009) 1.32

EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc (2003) 1.19

Endoscopic resection of early oesophageal cancer. Gut (2007) 1.15

Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. World J Surg Oncol (2007) 1.06

Spray cryotherapy for the treatment of glottic and subglottic stenosis. Laryngoscope (2010) 1.04

Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol (2005) 1.02

Wound healing and scarring after cryosurgery. Cryobiology (1984) 0.97

Bronchoscopic spray cryotherapy: assessment of safety and depth of airway injury. J Thorac Cardiovasc Surg (2009) 0.97

Total endoscopic resection of Barrett esophagus. Endoscopy (2008) 0.91

Response to spray cryotherapy in a patient with adenocarcinoma in the parietal pleura. Respiration (2009) 0.86

Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent. Am J Gastroenterol (2008) 0.80

Articles by these authors

Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48

Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91

Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15

Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA (2004) 6.98

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med (2011) 6.79

American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93

Comprehensive volumetric optical microscopy in vivo. Nat Med (2006) 5.19

Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc (2005) 4.78

Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17

Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients. Am J Gastroenterol (2013) 4.10

Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc (2010) 3.74

Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc (2007) 3.53

A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology (2004) 3.50

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44

Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial. Gastroenterology (2002) 3.32

Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28

Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc (2007) 3.23

Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc (2008) 3.13

Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol (2007) 2.94

Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc (2008) 2.94

American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.79

Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol (2008) 2.74

Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis. Am J Gastroenterol (2012) 2.70

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68

Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2009) 2.53

Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst (2004) 2.53

Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc (2008) 2.51

Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc (2011) 2.51

American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50

Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol (2011) 2.47

Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol (2009) 2.46

Multicenter, randomized, controlled trial of virtual-reality simulator training in acquisition of competency in colonoscopy. Gastrointest Endosc (2006) 2.33

Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med (2013) 2.32

Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc (2006) 2.31

Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 2.28

Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (2010) 2.28

Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video). Gastrointest Endosc (2007) 2.26

American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.23

Acute phosphate nephropathy--an emerging issue. Am J Gastroenterol (2007) 2.20

Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell (2012) 2.16

Digestive and liver diseases statistics, 2004. Gastroenterology (2004) 2.14

NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13

Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med (2009) 2.11

Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10

Directional distribution of neoplasia in Barrett's esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc (2013) 2.08

Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06

Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology (2009) 2.02

A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology (2009) 1.95

Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium. Gastroenterology (2013) 1.92

Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study. Gastrointest Endosc (2011) 1.82

Comparison of probe-based confocal laser endomicroscopy with virtual chromoendoscopy for classification of colon polyps. Gastroenterology (2009) 1.80

Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79

Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol (2009) 1.76

Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol (2013) 1.75

Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol (2003) 1.73

Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci (2009) 1.70

Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men. J Infect Dis (2011) 1.70

Hypoxemia during moderate sedation for gastrointestinal endoscopy: causes and associations. Digestion (2011) 1.67

Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc (2012) 1.67

A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67

Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol (2011) 1.66

The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology (2012) 1.65

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology (2012) 1.65

Quality in EUS: an assessment of baseline compliance and performance improvement by using the American Society for Gastrointestinal Endoscopy-American College of Gastroenterology quality indicators. Gastrointest Endosc (2009) 1.65

A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res (2009) 1.65

The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci (2010) 1.65

EUS-guided trucut needle biopsies in patients with solid pancreatic masses: a prospective study. Gastrointest Endosc (2004) 1.64

The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.64

Deep sedation occurs frequently during elective endoscopy with meperidine and midazolam. Am J Gastroenterol (2005) 1.61

Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2008) 1.57

Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterology (2012) 1.54

Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol (2006) 1.53

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52

Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut (2013) 1.52

Findings on endoscopic retrograde cholangiopancreatography and pancreatic function test in suspected chronic pancreatitis and negative cross-sectional imaging. Clin Gastroenterol Hepatol (2008) 1.51

The impact of the changing health care environment on the health and well-being of faculty at four medical schools. Acad Med (2006) 1.50

Pharmacological management of Cronkhite-Canada syndrome. Expert Opin Pharmacother (2003) 1.50

A 25-year analysis of the American College of Gastroenterology research grant program: factors associated with publication and advancement in academics. Am J Gastroenterol (2009) 1.49

Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc (2011) 1.49

Automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy. Gastrointest Endosc (2002) 1.48